Preview

Osteoporosis and Bone Diseases

Advanced search

KOSTNAYa MASSA I KOSTNYY METABOLIZM U DETEY S YuVENIL'NYM IDIOPATIChESKIM ARTRITOM

Abstract

This study describes bone metabolism in children withjuvenile idiopathic arthritis (JIA), association between disturbances of bone metabolism with inflammatory activity, juvenile arthritis disease course and therapy in 198 children. Low bone mineral density (BMD) for chronological age was detected by dual-energy X-ray absorptiometry of lumbar spine L1-L4 (densitometer Hologic QDR 4500C, with pediatric reference database) than Z -score < -2 SD in 36 children (18,2%), in 18 girls (15,5%) and in 18 boys (21,9%). Girls with low BMD received glucocorticoids (GCS) in 66,7 % cases, and girls with normal BMD received it in 26,5% cases (р=0,002). Girls with low BMD had lower height, weight, earlier age of disease onset and higher clinical and laboratory parameters of arthritis activity. Girls with low BMD had higher osteocalcin and tendency to decreased parathyroid hormone levels compared to the girls with normal BMD. Children who received GCS had specific stereotypic changes: boys had significantly lower bone mineral density and total Ca and girls had significantly lower bone mineral content and BMD (g/cm2 and Z-score), total Са, non-organic phosphate and total alkaline phosphatase activity. Patients with systemic arthritis had significantly lower mineralization and bone metabolism turnover compared to children with oligoarticular and polyarticular JIA subtypes. Independent predictors of skeletal mineralization were age onset f JIA (р<0,0001), duration of the disease (p<0,0001), hemoglobin level (р=0,004), total calcium level (р=0,024), a2-globulins level (р=0,046). Independent predictors of low BMD were physician’s assessment VAS (р=0,024), C-reactive protein (р=0,04), inorganic phosphate (р=0,05). Systemic glucocorticoids exposure elevated the risk of low BMD for chronological age realization in JIA patients (OR=1,96, 95%CI=0,76-5,05). Enhanced risk of low BMD was in polyarthicular (OR=2,53, 95%CI=0,66-9,65) and systemic JIA (OR=3,16, 95%CI=0,73-13,76). Thus, parameters of inflammation have negative influence on bone metabolism velocity, linear growth and accordingly bone mineralization. Described factors explain heterogeneity of mineralization disorders.

About the Authors

M. M. KOSTIK

k.m.n., dotsent kafedry gospital'noy pediatrii


M. M. MNUSKINA

zaveduyushchaya kliniko-diagnosticheskoy laboratoriey


I N MAKAROVA

vrach klinicheskoy laboratornoy diagnostiki


D. A. KUZ'MINA

k.m.n., dotsent kafedry terapevticheskoy stomatologii


L. A. ShchEPLYaGINA

professor, d.m.n., zav. laboratoriey ekologii i profilakticheskoy pediatrii


V. I. LARIONOVA

d.m.n., professor, nauchnyy rukovoditel' laboratorii s gruppoy ekogenetiki molekulyarnoy diagnostiki


References

1. Bumham JM, Shults J, Dubner SE, Sembhi H, Zemel BS, Leonard MB. Bone Density, Structure, and Strenth in Juvenile Idiopathic Arthritis. Importance of Disease severity and Muscle Deficits. Arthritis Rheum.-2008.-Vol.58(8).-p.2518-27

2. Lien G, Flat0 B, Haugen M, Vinje O, S0rskaar D, Dale K, Johnston V, Egeland T, F0rre 0. Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis: a long-term outcome study of one hundred five patients. Arthritis Rheum.-2003.-Vol. 48(8).- p.2214-23.

3. Celiker R, Bal S, Bakkaloglu A, Ozaydin E, Coskun T, Cetin A, Dinner F. Factors playing a role in the development of decreased bone mineral density in juvenile chronic arthritis. Rheumatol Int.-2003.-Vol.23(3).-p.127-9.

4. Caparbo VF, Prada F, Silva CAA, Regio PL, Pereira RMR. Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts “in vitro”. Clin Rheumatol.-2009.-Vol.28(1).-p.71-7

5. Spelling P, Bonfa E, Caparbo V.F, Pereira R.M.R. Osteoprotegerin/RANKL system imbalance in active polyarticular-onset juvenile idiopathic arthritis: a bone damage biomarker? Scand J Rheumatol.-2008.-Vol.37(6).-p.439-44

6. Valta H, Lahdenne P, Jalanko H, Aalto K, Mäkitie O. Bone health and growth in glucocorticoid-treated patients with juvenile idiopathic arthritis. J Rheumatol.-2007.-Vol.34(4).-p.831-6.

7. Cohran VC, Griffiths M, Heubi JE. Bone Mineral Density in Children Exposed to Chronic Glucocorticoid Therapy. Clin Pediatr (Phila).-2008.-Vol.47(5).-p.469-475

8. Aggarwal P, Aggarwal A, Gupta S, Misra R. Osteopenia is common in adult male patients with active juvenile idiopathic arthritis. J Rheumatol.-2006.-Vol. 33(8).-p.1642-5.

9. Haugen M, Lien G, Flat0 B, Kvammen J, Vinje O, S0rskaar D, F0rre 0. Young Adults with Juvenile Arthritis in Remission Attain Normal Peak Bone Mass at the Lumbar Spine and Forearm. Arthritis Rheum.-2000.-Vol.43(7).-p.1504-10

10. Cimaz R. Osteoporosis in childhood rheumatic diseases: prevention and therapy. Best Pract Res Clin Rheumatol.-2002.-Vol. 16(3).-p.397-409.

11. Lien G, Selvaag AM, Flat0 B, Haugen M, Vinje O, S0rskaar D, Dale K, Egeland T, F0rre 0. A two-year prospective controlled study of bone mass and bone turnover in children with early juvenile idiopathic arthritis. Arthritis Rheum.- 2005.-Vol.52(3).-p.833-40.

12. Dubner SE, Shults J, Leonard MB, Zemel BS, Sembhi H, Burnham JM. Assessment of Spine Bone Mineral Density in Juvenile Idiopathic Arthritis: Impact of Scan Projection. J Clin Densitom.-2008.-Vol.11(2).-p.302-8

13. Garnero P, Delmas PD. Noninvasive techniques for assessing skeletal changes in inflammatory arthritis: bone biomarkers. Curr Opin Rheumatol.-2004.-Vol.16.-p.428-34


Review

For citations:


KOSTIK M.M., MNUSKINA M.M., MAKAROVA I.N., KUZ'MINA D.A., ShchEPLYaGINA L.A., LARIONOVA V.I. KOSTNAYa MASSA I KOSTNYY METABOLIZM U DETEY S YuVENIL'NYM IDIOPATIChESKIM ARTRITOM. Osteoporosis and Bone Diseases. 2011;14(3):19-23. (In Russ.)

Views: 506


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2072-2680 (Print)
ISSN 2311-0716 (Online)